Universe Pharmaceutical Class AUPC

13F holders, Q3 2024 (September 30)
9holders +7
8new positions
1sold out
2famous investors
$0.24avg. 13F price*

At the end of Q3 2024, 9 institutions reported holding Universe Pharmaceutical Class A (UPC) in their 13F filings, up 7 from Q2 2024. 8 opened new positions and 1 sold out. The largest holders were UBS Group AG ($59K), MML Investors Services, LLC ($57K) and Two Sigma Securities, LLC ($22K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).

Company
Universe Pharmaceutical Class A
CUSIP
G9442G112
Latest filing quarter
Q3 2024

History

Number of 13F holders

0246810 Q1 2024: 2Q1 2024Q2 2024: 2Q2 2024Q3 2024: 9Q3 2024

Total Exit/New Position Q2 2024 → Q3 2024

InstitutionsTotal Value
New Positions8$109K
Exits1$0

All 13F filers, Q2 2024 → Q3 2024: 686,234 shares bought and 300 shares sold, net +685,934 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 9 holders

UBS Group AG 0.00% Add +4529.8% 242,460 $59K
MML Investors Services, LLC 0.00% New 234,260 $57K
Two Sigma Securities, LLC 0.00% New 90,371 $22K
Renaissance Technologies 0.00% New 39,267 $10K
Quadrature Capital Ltd 0.00% New 24,891 $6K
Virtu Financial LLC 0.00% New 16,585 $4K
StoneX Group Inc. 0.00% New 15,008 $4K
XTX Topco Ltd 0.00% New 14,820 $4K
Millennium Management 0.00% New 13,809 $3K

"% of holder's portfolio" is UPC's weight in each manager's 13F, not the share of Universe Pharmaceutical Class A the manager owns.